[Development of the ultra-fine size reduction method of slightly soluble medicinal crystals. III. Inference of origin for ultra-fine size reduction of oxolinic acid crystal].
D000327:Adsorption; D003460:Crystallization; D010093:Oxolinic Acid; D010316:Particle Size; D012995:Solubility; D013501:Surface-Active Agents
D013501:Surface-Active Agents; D010093:Oxolinic Acid